Singapore, Singapore

See Chen Goh

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Life Technologies Corporation, Life Technologies Holdings Pte Limited. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of See Chen Goh

Introduction

See Chen Goh is a notable inventor based in Singapore, recognized for his contributions to the field of biotechnology. He has developed innovative solutions that enhance scientific research and applications. His work has had a significant impact on the industry, particularly in the area of electroporation.

Latest Patents

One of See Chen Goh's key inventions is the electroporation pipette. This device is designed to facilitate the introduction of substances into cells through the application of an electric field. His innovative approach has led to the granting of 1 patent for this technology.

Career Highlights

Throughout his career, See Chen Goh has worked with prominent companies in the biotechnology sector. He has been associated with Life Technologies Corporation and Life Technologies Holdings Pte Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in the field.

Collaborations

See Chen Goh has collaborated with talented individuals in his field, including coworkers such as Wee Liam Lim and Josh Mead. These collaborations have fostered a creative environment that encourages innovation and the development of new technologies.

Conclusion

In summary, See Chen Goh is a distinguished inventor whose work in biotechnology, particularly with the electroporation pipette, has made a lasting impact. His collaborations and career experiences have further enriched his contributions to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…